R&D Tax Incentive Funding vs Equity Raising: Which Is Right for Your Business?

Developing a new product, testing innovative technology or bringing a breakthrough idea to market takes more than expertise and ambition. It takes money. And for many Australian businesses investing in research and development (R&D), finding that money at the right time can be one of the biggest challenges.

You might have a promising project, a capable team and a clear commercial opportunity. But if cash is tied up in ongoing R&D expenses, progress can slow considerably.

Traditionally, businesses looking for growth capital have turned to investors. However, giving away part of your company isn't always the most attractive option, particularly when you're still building its value.

That's where R&D Tax funding in Australia offers an alternative worth considering.

By borrowing against an anticipated R&D Tax Incentive benefit, eligible businesses may be able to access working capital without issuing new shares.

So, how does this approach compare with raising equity? And which option makes more sense for your business?

Let's explore the differences.

Understanding R&D Tax Incentive Funding

The Australian Government's Research and Development Tax Incentive (R&DTI) encourages businesses to invest in innovation by providing tax offsets for eligible R&D expenditure.

Under the current rules, eligible companies with aggregated annual turnover below $20 million may receive a refundable tax offset calculated using their corporate tax rate plus an 18.5% premium. Larger companies generally access a non-refundable offset, subject to the applicable rules.

While this incentive provides valuable financial support, there's a practical challenge: businesses generally need to incur the expenditure before claiming the benefit through the tax system.

That creates a timing gap.

Imagine an Australian technology company spending heavily on software development, engineering staff and product testing. Its anticipated R&D tax refund could be substantial, but the business still needs to pay wages, suppliers and operating expenses in the meantime.

R&D Tax Incentive funding helps address this problem.

Specialist financiers such as R&D Capital Partners (R&DCP) offer funding secured against a company's projected R&D tax benefit.

Instead of waiting until the expected benefit is received, an eligible business can potentially access part of its value earlier.

Importantly, this is a loan, not an additional government grant. The company remains responsible for repayment under the agreed terms.

What Is Equity Raising?

Equity raising works differently.

Rather than borrowing money, a business sells an ownership stake to investors in exchange for capital.

These investors might include angel investors, venture capital firms, private equity groups or strategic industry partners.

For example, if your business is valued at $4 million before an investment and an investor contributes $1 million, that investor would typically own 20% of the company after the transaction, assuming a straightforward share issue.

The immediate attraction is that equity investment generally doesn't require scheduled loan repayments.

However, the trade-off is ownership.

Investors become shareholders, potentially gaining voting rights, information rights, board representation or influence over important business decisions.

Equity raising can be highly effective when a business needs substantial capital to expand. But it may be less appealing when the immediate objective is simply to cover R&D expenses until an expected tax benefit arrives.

R&D Tax Funding vs Equity Raising: Key Differences

Both options can provide much-needed capital, but they solve different financial problems.

  Factor

 R&D Tax Incentive Funding

 Equity Raising

   Ownership

 No new shares issued

 Existing ownership diluted

   Repayment

 Loan must be repaid

 Generally no loan repayment

   Funding amount

 Linked to eligible anticipated tax benefit

 Based on investor appetite and valuation

   Cost

 Interest and applicable fees

 Ownership and future value surrendered

   Cash runway

 Bridges a funding gap

 Can support longer-term growth

   Control

 Existing shareholders retain ownership

 Investors may receive governance rights

   Main risk

 Debt obligations and tax benefit uncertainty

 Dilution and investor expectations

  Neither option is automatically better. The right choice depends on what you're funding, how much capital you need and where your business sits in its growth journey.

1. Cash Runway: How Long Can Your Business Keep Operating?

Cash runway is the amount of time your business can continue operating before it needs additional funding.

For R&D-intensive companies, maintaining sufficient runway is essential. Development timelines can change, technical problems can emerge and commercialisation often takes longer than expected.

How R&D Tax funding can extend your runway

Suppose your company has enough cash to operate for another four months, but you anticipate receiving an R&D tax refund later in the year.

Without additional capital, you might need to reduce development spending, delay hiring or put important projects on hold.

Borrowing against your anticipated refund could provide a temporary cash flow bridge, allowing you to continue eligible development activities while waiting for the tax benefit.

R&D Capital Partners specifically identifies extending cash runway as a benefit of its prepayment funding service.

This can be particularly useful when a business expects a future cash inflow but needs funds sooner.

How equity raising affects runway

Equity investment can provide a larger pool of capital, potentially supporting operations over several years.

That makes it attractive for businesses planning significant expansion, recruitment, infrastructure investment or entry into new markets.

However, raising equity can involve investor negotiations, due diligence, valuation discussions and legal documentation.

If your business needs working capital relatively quickly, a lengthy capital-raising process may create additional pressure.

The key question: Are you bridging a temporary funding gap, or financing a much larger growth strategy?

2. Ownership Dilution: How Much of Your Business Are You Willing to Give Up?

For founders, ownership dilution is often one of the most important considerations.

When you raise equity, your percentage ownership typically decreases.

This might seem manageable during an early funding round, but repeated capital raises can significantly reduce a founder's long-term stake.

Consider a simple example.

You currently own 100% of your business. An investor offers $500,000 in exchange for 20% ownership.

You receive the funding, but your stake falls to 80%.

If the company eventually sells for $10 million, that 20% stake could represent $2 million in value, assuming no further ownership changes.

Of course, investor capital might help the business achieve a much higher valuation than it could otherwise reach. Dilution isn't necessarily a bad outcome.

But it is a meaningful financial decision.

The non-dilutive advantage of R&D Tax funding

One of the main attractions of R&D Tax Incentive funding is that it doesn't require issuing additional shares.

R&DCP specifically highlights avoiding equity dilution as a benefit of its lending structure.

This allows founders and existing shareholders to retain their ownership percentages while accessing funding linked to anticipated R&D tax benefits.

For companies that believe their valuation could increase after reaching the next technical or commercial milestone, maintaining ownership can be particularly valuable.

It also gives founders the option to consider equity investment later, potentially from a stronger negotiating position.

3. Comparing the True Cost of Funding

Every funding option has a cost. The important thing is understanding how that cost is calculated.

The cost of R&D Tax Incentive funding

With R&D funding loans, businesses generally pay interest and any applicable establishment or other contractual fees.

The overall cost depends on factors such as the amount borrowed, loan duration, repayment arrangements and agreed pricing.

R&D Capital Partners outlines a funding structure involving an establishment fee, monthly interest payments and repayment from the anticipated tax refund.

Before accepting finance, businesses should understand the total expected cost, security requirements and what happens if their R&D claim is delayed or reduced.

The cost of raising equity

Equity financing typically avoids interest and scheduled principal repayments.

However, it involves giving investors a share of the company's future value.

That cost can be difficult to quantify when the investment is made.

If the company grows significantly, the economic value of the ownership surrendered could exceed the cost of short-term debt financing.

On the other hand, if an investor brings substantial expertise, commercial relationships or strategic opportunities, their contribution may justify the dilution.

The comparison shouldn't simply be interest versus no interest.

It should be the total financial and strategic impact of each funding arrangement.

4. Speed, Flexibility and Funding Certainty

Timing matters when you're managing an R&D project.

A delayed funding decision can mean postponed trials, interrupted product development or missed opportunities.

Specialist R&D funding may provide a more targeted process because the lender focuses on the anticipated tax benefit, eligible expenditure and the company's financial circumstances.

R&D Capital Partners offers funding arrangements linked to prior-year expenditure, current-year expenditure and certain longer-term R&D plans.

Its published service information describes drawdowns linked to eligible expenditure and lender due diligence. Actual funding remains subject to approval and contractual conditions.

Equity raising is less predictable.

You need to identify suitable investors, demonstrate the commercial opportunity, agree on valuation and negotiate investment terms.

For some companies, this process is worthwhile. For others, particularly those seeking a relatively modest cash flow bridge, it can become a distraction from the R&D itself.

Neither funding route is guaranteed, so businesses should plan conservatively rather than assume money will arrive by a particular date.

5. When Does R&D Tax Funding Make More Sense?

R&D Tax Incentive funding can be particularly attractive when your business has a clearly defined R&D program and expects an eligible tax benefit.

It may be worth considering if:

• Your business is investing heavily in eligible R&D activities.
• You anticipate receiving a refundable R&D tax offset.
• You need working capital to maintain development momentum.
• You want to avoid diluting existing shareholders.
• You expect to reach important milestones before your next capital raise.
• You have a realistic plan for repaying the loan.

For example, an Australian medical technology company might need additional funding to complete product testing before its next investment round.

Accessing part of its anticipated R&D refund could help the company reach that milestone without immediately selling more equity.

However, R&D funding is not suitable for every business. Eligibility, expenditure documentation, expected refund amounts and repayment capacity all need careful assessment.

A projected tax benefit is not a guaranteed payment. Claims may be reviewed, adjusted or delayed, and borrowers need to understand their obligations if the anticipated refund is lower than expected.

6. When Is Equity Raising the Better Choice?

Equity investment may be more appropriate when your business needs capital beyond what its anticipated R&D tax benefit can support.

This might include funding for:

• Large-scale commercialisation or international expansion.
• Acquisitions, major equipment purchases or infrastructure.
• Sales and marketing growth.
• Long-term operations before the business generates meaningful revenue.
• Strategic partnerships requiring specialist investor expertise.

Equity can also make sense when the business cannot comfortably service debt or when future cash inflows are too uncertain to support borrowing.

A strong investor may bring much more than money, including industry connections, mentoring, governance expertise and access to future investment rounds.

For some businesses, these advantages outweigh the dilution.

7. Can You Combine R&D Tax Funding and Equity Raising?

Absolutely. In fact, the two approaches can complement each other.

Consider a growing Australian software company preparing for a Series A investment round.

The founders believe completing an important product milestone will strengthen their valuation. However, they need additional working capital to finish development.

Rather than raising equity immediately, the company might use R&D Tax Incentive funding to support its eligible development expenditure.

Once the milestone is achieved, the business could approach investors with a more developed product and stronger commercial evidence.

This strategy may improve its negotiating position, although a higher valuation is never guaranteed.

Alternatively, a company might use equity investment for long-term expansion while relying on R&D prepayment finance to manage shorter-term cash flow requirements.

The goal is to choose funding sources that match the timing, purpose and risk of each financial need.

How R&D Capital Partners Can Help

At R&D Capital Partners, we understand that innovation doesn't always move at the same pace as the tax system.

Our specialist R&D Tax Incentive prepayment funding service is designed to help eligible Australian businesses access capital secured against anticipated R&D tax benefits.

Rather than issuing new shares, businesses may be able to borrow against their projected refund and retain existing ownership.

Our funding arrangements can support different stages of the R&D cycle, including qualifying prior-year and current-year expenditure.

By focusing on R&D eligibility and the anticipated tax benefit, we aim to provide a practical alternative to traditional funding options.

Explore our R&D Tax Incentive funding services to understand the available structures and application process.

Final Thoughts: Choosing the Right Funding Strategy

There's no universal answer to the question of R&D Tax funding versus equity raising.

If your business needs substantial long-term growth capital and would benefit from strategic investors, equity raising could be the right choice.

But if your immediate challenge is bridging the gap between R&D expenditure and an anticipated tax refund, specialist R&D funding may offer a more suitable solution.

The biggest difference is what you're giving up.

With equity, you're sharing future ownership and potential value. With R&D Tax Incentive funding, you're taking on a repayment obligation and financing costs while retaining your existing equity.

Before deciding, assess your cash runway, projected tax benefit, borrowing costs, repayment capacity and longer-term growth plans.

Looking for R&D Tax funding in Australia without giving away equity?

Contact R&D Capital Partners to discuss your R&D activities, anticipated tax benefit and potential funding options.

Frequently Asked Questions

Is R&D Tax Incentive funding the same as receiving an R&D tax refund?

No. R&D Tax Incentive funding involves borrowing against an anticipated tax benefit. The refund or offset itself is administered through the Australian tax system, while the loan is provided by a financier and must be repaid under its terms.

Does R&D Tax funding dilute company ownership?

A conventional R&D tax prepayment loan does not require issuing new shares, so existing ownership percentages remain unchanged. However, borrowers still incur financing costs and contractual obligations.

Can startups access R&D Tax funding in Australia?

Potentially. Eligible startups conducting qualifying R&D may be able to access specialist funding, depending on their anticipated tax benefit, expenditure records, financial position and lender requirements.



Is R&D Tax funding better than venture capital?

It depends on your needs. R&D funding can help bridge short-term cash flow gaps without equity dilution, while venture capital may provide larger amounts of growth capital and valuable strategic support.